The DOI matches its Crossref record; 211 of the 211 references it cites were found in a registry or an index.
Coexistence of passive and carrier-mediated processes in drug transport
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular properties that influence the oral bioavailability of drug candidates
Veber, D. F., Johnson, S. R., Cheng, H.-Y., Smith, B. R., Ward, K. W., & Kopple, K. D. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020017n · Cited by 8,420
Amidon, G. L., Lennernäs, H., Shah, V. P., & Crison, J. R. (1995) · Pharmaceutical Research · doi:10.1023/a:1016212804288 · Cited by 5,430
Self-citationMembrane transporters in drug development
The International Transporter Consortium, Giacomini, K. M., Huang, S.-M., Tweedie, D. J., Benet, L. Z., Brouwer, K. L. R., Chu, X., Dahlin, A., Evers, R., Fischer, V., et al. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3028 · Cited by 3,340
Schinkel, A. H., Smit, J. J. M., van Tellingen, O., Beijnen, J. H., Wagenaar, E., van Deemter, L., Mol, C. A. A. M., van der Valk, M. A., Robanus-Maandag, E. C., te Riele, H. P. J., et al. (1994) · Cell · doi:10.1016/0092-8674(94)90212-7 · Cited by 2,281
Determination of drug permeability and prediction of drug absorption in Caco-2 monolayers
Hubatsch, I., Ragnarsson, E. G. E., & Artursson, P. (2007) · Nature Protocols · doi:10.1038/nprot.2007.303 · Cited by 1,499
Self-citationReconstitution of Cell Membrane Structure in vitro and its Transformation into an Excitable System
MUELLER, P., RUDIN, D. O., TI TIEN, H., & WESCOTT, W. C. (1962) · Nature · doi:10.1038/194979a0 · Cited by 1,404
Wu, C.-Y., & Benet, L. Z. (2005) · Pharmaceutical Research · doi:10.1007/s11095-004-9004-4 · Cited by 1,401
Kansy, M., Senner, F., & Gubernator, K. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm970530e · Cited by 1,304
Self-citationHigh throughput artificial membrane permeability assay for blood–brain barrier
Di, L., Kerns, E. H., Fan, K., McConnell, O. J., & Carter, G. T. (2003) · European Journal of Medicinal Chemistry · doi:10.1016/s0223-5234(03)00012-6 · Cited by 1,195
Self-citationRole of P-Glycoprotein in Pharmacokinetics: Clinical Implications
Lin, J. H., & Yamazaki, M. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342010-00003 · Cited by 998
MDCK (Madin-Darby Canine Kidney) Cells: A Tool for Membrane Permeability Screening
Irvine, J. D., Takahashi, L., Lockhart, K., Cheong, J., Tolan, J. W., Selick, H. E., & Grove, J. R. (1999) · Journal of Pharmaceutical Sciences · doi:10.1021/js9803205 · Cited by 980
Rodgers, T., & Rowland, M. (2006) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20502 · Cited by 946
Polar Molecular Surface Properties Predict the Intestinal Absorption of Drugs in Humans
Palm, K., Stenberg, P., Luthman, K., & Artursson1, P. (1997) · Pharmaceutical Research · doi:10.1023/a:1012188625088 · Cited by 756
Self-citationLown, K. S., Mayo, R. R., Leichtman, A. B., Hsiao, H.-L., Turgeon, D. K., Schmiedlin-Ren, P., Brown, M. B., Guo, W., Rossi, S. J., Benet, L. Z., et al. (1997) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(97)90027-8 · Cited by 680
Doan, K. M. M., Humphreys, J. E., Webster, L. O., Wring, S. A., Shampine, L. J., Serabjit-Singh, C. J., Adkison, K. K., & Polli, J. W. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.039255 · Cited by 614
OATP and P-Glycoprotein Transporters Mediate the Cellular Uptake and Excretion of Fexofenadine
Cvetkovic, M., Leake, B., Fromm, M. F., Wilkinson, G. R., & Kim, R. B. (1999) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15235-x · Cited by 597
Hilgendorf, C., Ahlin, G., Seithel, A., Artursson, P., Ungell, A.-L., & Karlsson, J. (2007) · Drug Metabolism and Disposition · doi:10.1124/dmd.107.014902 · Cited by 583
Self-citationThe Role of ABC Transporters in Drug Resistance, Metabolism and Toxicity
Glavinas, H., Krajcsi, P., Cserepes, J., & Sarkadi, B. (2004) · Current Drug Delivery · doi:10.2174/1567201043480036 · Cited by 558
A Comparison of Physiochemical Property Profiles of Development and Marketed Oral Drugs
Wenlock, M. C., Austin, R. P., Barton, P., Davis, A. M., & Leeson, P. D. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm021053p · Cited by 546
Zhao, Y. H., Le, J., Abraham, M. H., Hersey, A., Eddershaw, P. J., Luscombe, C. N., Boutina, D., Beck, G., Sherborne, B., Cooper, I., et al. (2001) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.1031 · Cited by 526
Methods and Principles in Medicinal Chemistry
(2008) · Methods and principles in medicinal chemistry · doi:10.1002/series6138 · Cited by 514
Permeability of small nonelectrolytes through lipid bilayer membranes
Walter, A., & Gutknecht, J. (1986) · The Journal of Membrane Biology · doi:10.1007/bf01870127 · Cited by 502
Lennernaäs, H. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js970332a · Cited by 500
Transporters as a determinant of drug clearance and tissue distribution
Shitara, Y., Horie, T., & Sugiyama, Y. (2006) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.12.003 · Cited by 496
Wohnsland, F., & Faller, B. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm001020e · Cited by 492
Self-citationCarrier-mediated cellular uptake of pharmaceutical drugs: an exception or the rule?
Dobson, P. D., & Kell, D. B. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2438 · Cited by 475 · cited 1×
“Consequently, it would be interesting to discuss whether carrier-mediated transport is the ubiquitous and dominant mechanism of biological membrane permeation for most drugs in most organ”
BackgroundON THE MECHANISM OF INTESTINAL ABSORPTION OF DRUGS
Hogben, C. A. M., Tocco, D. J., Brodie, B. B., & Schanker, L. S. (1959) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12995-9 · Cited by 474
Comprehensive medicinal chemistry II
Taylor, J. B. (2007) · Cited by 468
Obach, R. S., Lombardo, F., & Waters, N. J. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.020479 · Cited by 462
Interrelationship Between Substrates and Inhibitors of Human CYP3A and P-Glycoprotein
Kirn, R. B., Wandel, C., Leake, B., Cvetkovic, M., Fromm, M. F., Dempsey, P. J., Roden, M. M., Belas, F., Chaudhary, A. K., Roden, D. M., et al. (1999) · Pharmaceutical Research · doi:10.1023/a:1018877803319 · Cited by 454
Ivermectin sensitivity in collies is associated with a deletion mutation of the mdr1 gene
Mealey, K. L., Bentjen, S. A., Gay, J. M., & Cantor, G. H. (2001) · Pharmacogenetics · doi:10.1097/00008571-200111000-00012 · Cited by 454
Winiwarter, S., Bonham, N. M., Ax, F., Hallberg, A., Lennernäs, H., & Karlén, A. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm9810102 · Cited by 453
Absorption and Drug Development: Solubility, Permeability, and Charge State
Avdeef, A. (2003) · Cited by 451
Self-citationSun, D., Lennernas, H., Welage, L. S., Barnett, J. L., Landowski, C. P., Foster, D., Fleisher, D., Lee, K.-D., & Amidon, G. L. (2002) · Pharmaceutical Research · doi:10.1023/a:1020483911355 · Cited by 447
Feng, B., Mills, J. B., Davidson, R. E., Mireles, R. J., Janiszewski, J. S., Troutman, M. D., & de Morais, S. M. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.107.017434 · Cited by 440
The Role of Transporters in the Pharmacokinetics of Orally Administered Drugs
Shugarts, S., & Benet, L. Z. (2009) · Pharmaceutical Research · doi:10.1007/s11095-009-9924-0 · Cited by 438
Poulin, P., & Theil, F. (2000) · Journal of Pharmaceutical Sciences · doi:10.1002/(sici)1520-6017(200001)89:1<16::aid-jps3>3.0.co;2-e · Cited by 424
Mechanistic Approaches to Volume of Distribution Predictions: Understanding the Processes
Rodgers, T., & Rowland, M. (2007) · Pharmaceutical Research · doi:10.1007/s11095-006-9210-3 · Cited by 420
Intestinal Drug Transporter Expression and the Impact of Grapefruit Juice in Humans
Glaeser, H., Bailey, D. G., Dresser, G. K., Gregor, J. C., Schwarz, U. I., McGrath, J. S., Jolicoeur, E., Lee, W., Leake, B. F., Tirona, R. G., et al. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100056 · Cited by 407
Using the Golden Triangle to optimize clearance and oral absorption
Johnson, T. W., Dress, K. R., & Edwards, M. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.08.045 · Cited by 392
Cao, X., Gibbs, S. T., Fang, L., Miller, H. A., Landowski, C. P., Shin, H.-C., Lennernas, H., Zhong, Y., Amidon, G. L., Yu, L. X., et al. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-9041-2 · Cited by 388
Blood-Brain Barrier Permeation: Molecular Parameters Governing Passive Diffusion
Fischer, H., Gottschlich, R., & Seelig, A. (1998) · Journal of Membrane Biology · doi:10.1007/s002329900434 · Cited by 371
Self-citationEnglund, G., Rorsman, F., Rönnblom, A., Karlbom, U., Lazorova, L., Gråsjö, J., Kindmark, A., & Artursson, P. (2006) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2006.04.010 · Cited by 368
Self-citationZhu, C., Jiang, L., Chen, T.-M., & Hwang, K.-K. (2002) · European Journal of Medicinal Chemistry · doi:10.1016/s0223-5234(02)01360-0 · Cited by 351
Watanabe, T., Kusuhara, H., Maeda, K., Shitara, Y., & Sugiyama, Y. (2009) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.146647 · Cited by 351
Analysis and update of the human solute carrier (SLC) gene superfamily
He, L., Vasiliou, K., & Nebert, D. W. (2009) · Human Genomics · doi:10.1186/1479-7364-3-2-195 · Cited by 349
Absorption and Drug Development: Solubility, Permeability, and Charge State
Avdeef, A. (2003) · Wiley eBooks · doi:10.1002/047145026x · Cited by 349
Self-citationCamenisch, G., Alsenz, J., van de Waterbeemd, H., & Folkers, G. (1998) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(97)10019-7 · Cited by 347
EVALUATION OF DRUG-DRUG INTERACTION IN THE HEPATOBILIARY AND RENAL TRANSPORT OF DRUGS
Shitara, Y., Sato, H., & Sugiyama, Y. (2005) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.44.101802.121444 · Cited by 336
Mechanisms of Clinically Relevant Drug Interactions Associated with Tacrolimus
Christians, U., Jacobsen, W., Benet, L. Z., & Lampen, A. (2002) · Clinical Pharmacokinetics · doi:10.2165/00003088-200241110-00003 · Cited by 323
Matsson, P., Pedersen, J. M., Norinder, U., Bergström, C. A. S., & Artursson, P. (2009) · Pharmaceutical Research · doi:10.1007/s11095-009-9896-0 · Cited by 316
Self-citationIntestinal permeability and its relevance for absorption and elimination
Lennernäs, H. (2007) · Xenobiotica · doi:10.1080/00498250701704819 · Cited by 304
Valacyclovir: A Substrate for the Intestinal and Renal Peptide Transporters PEPT1 and PEPT2
Ganapathy, M. E., Huang, W. Y., Wang, H., Ganapathy, V., & Leibach, F. H. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8628 · Cited by 301
Hosea, N. A., Collard, W. T., Cole, S., Maurer, T. S., Fang, R. X., Jones, H., Kakar, S. M., Nakai, Y., Smith, B. J., Webster, R., et al. (2009) · The Journal of Clinical Pharmacology · doi:10.1177/0091270009333209 · Cited by 300
Han, H.-K., de Vrueh, R. L. A., Rhie, J. K., Covitz, K.-M. Y., Smith, P. L., Lee, C.-P., Oh, D.-M., Sadee, W., & Amidon1, G. L. (1998) · Pharmaceutical Research · doi:10.1023/a:1011919319810 · Cited by 297
Bailey, D. G., Dresser, G. K., Leake, B. F., & Kim, R. B. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100104 · Cited by 287
Intestinal Drug Absorption and Metabolism in Cell Cultures: Caco-2 and Beyond
Artursson, P., & Borchardt, R. T. (1997) · Pharmaceutical Research · doi:10.1023/a:1012155124489 · Cited by 280
Self-citationProfiling drug-like properties in discovery research
Di, L., & Kerns, E. H. (2003) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(03)00055-3 · Cited by 278
Self-citationStructure–activity relationship of P-glycoprotein substrates and modifiers
Seelig, A., & Landwojtowicz, E. (2000) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(00)00177-9 · Cited by 275
Kerns, E. H., Di, L., Petusky, S., Farris, M., Ley, R., & Jupp, P. (2004) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20075 · Cited by 275
Self-citationPeltier, S., Oger, J.-M., Lagarce, F., Couet, W., & Benoît, J.-P. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-0022-2 · Cited by 274
Fenner, K., Troutman, M., Kempshall, S., Cook, J., Ware, J., Smith, D., & Lee, C. (2009) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2008.195 · Cited by 272
Tacrolimus oral bioavailability doubles with coadministration of ketoconazole*
Floren, L. C., Bekersky, I., Benet, L. Z., Mekki, Q., Dressler, D., Lee, J. W., Roberts, J. P., & Hebert, M. F. (1997) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(97)90150-8 · Cited by 268
IAM chromatography: an in vitro screen for predicting drug membrane permeability
Pidgeon, C., Ong, S., Liu, H., Qiu, X., Pidgeon, M., Dantzig, A. H., Munroe, J., Hornback, W. J., & Kasher, J. S. (1995) · Journal of Medicinal Chemistry · doi:10.1021/jm00004a004 · Cited by 267
Hayeshi, R., Hilgendorf, C., Artursson, P., Augustijns, P., Brodin, B., Dehertogh, P., Fisher, K., Fossati, L., Hovenkamp, E., Korjamo, T., et al. (2008) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2008.08.004 · Cited by 263
Self-citationA Novel Design of Artificial Membrane for Improving the PAMPA Model
Chen, X., Murawski, A., Patel, K., Crespi, C. L., & Balimane, P. V. (2008) · Pharmaceutical Research · doi:10.1007/s11095-007-9517-8 · Cited by 262
Current industrial practices of assessing permeability and P-glycoprotein interaction
Balimane, P. V., Han, Y.-H., & Chong, S. (2006) · The AAPS Journal · doi:10.1208/aapsj080101 · Cited by 258
Unmasking the dynamic interplay between efflux transporters and metabolic enzymes
Benet, L. Z., Cummins, C. L., & Wu, C. Y. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2002.12.002 · Cited by 256
Hou, T., & Xu, X. (2002) · Journal of Molecular Modeling · doi:10.1007/s00894-002-0101-1 · Cited by 255
Variability in Caco-2 and MDCK Cell-Based Intestinal Permeability Assays
Volpe, D. A. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21010 · Cited by 252
PAMPA—critical factors for better predictions of absorption
Avdeef, A., Bendels, S., Di, L. I., Faller, B., Kansy, M., Sugano, K., & Yamauchi, Y. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21068 · Cited by 240
Self-citationMonocarboxylic acid permeation through lipid bilayer membranes
Walter, A., & Gutknecht, J. (1984) · The Journal of Membrane Biology · doi:10.1007/bf01870573 · Cited by 235
Sasaki, M., Suzuki, H., Ito, K., Abe, T., & Sugiyama, Y. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109081200 · Cited by 228
Fricker, G., Drewe, J., Huwyler, J., Gutmann, H., & Beglinger, C. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb15612.x · Cited by 223
Avdeef, A. (2005) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.1.2.325 · Cited by 222
Self-citationPharmaceutical and pharmacological importance of peptide transporters
Brandsch, M., Knütter, I., & Bosse-Doenecke, E. (2008) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.60.5.0002 · Cited by 221
Caco-2 permeability of weakly basic drugs predicted with the Double-Sink PAMPA method
Avdeef, A., Artursson, P., Neuhoff, S., Lazorova, L., Gråsjö, J., & Tavelin, S. (2005) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2004.11.011 · Cited by 215
Self-citationThe relationship between permeant size and permeability in lipid bilayer membranes
Xiang, T.-X., & Anderson, B. D. (1994) · The Journal of Membrane Biology · doi:10.1007/bf00232899 · Cited by 215
Lombardo, F., Obach, R. S., Shalaeva, M. Y., & Gao, F. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm0200409 · Cited by 213
Ieiri, I., Higuchi, S., & Sugiyama, Y. (2009) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425250902976854 · Cited by 212
Isolation of a Family of Organic Anion Transporters from Human Liver and Kidney
Sun, W., Wu, R. R., van Poelje, P. D., & Erion, M. D. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4774 · Cited by 212
PAMPA—a drug absorption in vitro model
Bermejo, M., Avdeef, A., Ruiz, A., Nalda, R., Ruell, J. A., Tsinman, O., González, I., Fernández, C., Sánchez, G., Garrigues, T. M., et al. (2004) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2003.10.009 · Cited by 206
Self-citationNeuhoff, S., Ungell, A.-L., Zamora, I., & Artursson, P. (2003) · Pharmaceutical Research · doi:10.1023/a:1025032511040 · Cited by 206
Self-citationPalm, K., Luthman, K., Ungell, A.-L., Strandlund, G., Beigi, F., Lundahl, P., & Artursson, P. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm980313t · Cited by 206
Self-citationSugano, K., Hamada, H., Machida, M., & Ushio, H. (2001) · SLAS Discovery · doi:10.1177/108705710100600309 · Cited by 202
Self-citationHou, T. J., Zhang, W., Xia, K., Qiao, X. B., & Xu, X. J. (2004) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci049884m · Cited by 201
Drug Liposome Partitioning as a Tool for the Prediction of Human Passive Intestinal Absorption
Balon, K., Riebesehl, B. U., & Müller, B. W. (1999) · Pharmaceutical Research · doi:10.1023/a:1018882221008 · Cited by 199
Human Hepatobiliary Transport of Organic Anions Analyzed by Quadruple-Transfected Cells
Kopplow, K., Letschert, K., König, J., Walter, B., & Keppler, D. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.014605 · Cited by 197
Comparative Studies on in Vitro Methods for Evaluating in Vivo Function of MDR1 P-Glycoprotein
Adachi, Y., Suzuki, H., & Sugiyama, Y. (2001) · Pharmaceutical Research · doi:10.1023/a:1013358126640 · Cited by 195
Ottaviani, G., Martel, S., & Carrupt, P.-A. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060230+ · Cited by 194
Ahlin, G., Karlsson, J., Pedersen, J. M., Gustavsson, L., Larsson, R., Matsson, P., Norinder, U., Bergström, C. A. S., & Artursson, P. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm8003152 · Cited by 190
Self-citationAn Integrated Model for Determining Causes of Poor Oral Drug Absorption
Yu, L. X. (1999) · Pharmaceutical Research · doi:10.1023/a:1018911728161 · Cited by 185
Pade, V., & Stavchansky, S. (1997) · Pharmaceutical Research · doi:10.1023/a:1012111008617 · Cited by 185
Martin, Y. C. (1981) · Journal of Medicinal Chemistry · doi:10.1021/jm00135a001 · Cited by 182
The Role of Passive Transbilayer Drug Movement in Multidrug Resistance and Its Modulation
Eytan, G. D., Regev, R., Oren, G., & Assaraf, Y. G. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.22.12897 · Cited by 182
Flaten, G. E., Dhanikula, A. B., Luthman, K., & Brandl, M. (2006) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.08.007 · Cited by 180
Fredriksson, R., Nordström, K. J. V., Stephansson, O., Hägglund, M. G. A., & Schiöth, H. B. (2008) · FEBS Letters · doi:10.1016/j.febslet.2008.10.016 · Cited by 175
Harrigan, P. R., Wong, K. F., Redelmeier, T. E., Wheeler, J. J., & Cullis, P. R. (1993) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(93)90218-o · Cited by 168
Testa, B., Krämer, S. D., Wunderli‐Allenspach, H., & Folkers, G. (2006) · Cited by 166
Linnankoski, J., Mäkelä, J., Palmgren, J., Mauriala, T., Vedin, C., Ungell, A., Lazorova, L., Artursson, P., Urtti, A., & Yliperttula, M. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21961 · Cited by 164
Self-citationYasui‐Furukori, N., Uno, T., SUGAWARA, K., & TATEISHI, T. (2005) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2004.08.026 · Cited by 162
Varma, M. V. S., Sateesh, K., & Panchagnula, R. (2005) · Molecular Pharmaceutics · doi:10.1021/mp0499196 · Cited by 161
Troutman, M. D., & Thakker, D. R. (2003) · Pharmaceutical Research · doi:10.1023/a:1025001131513 · Cited by 159
Di, L., Kerns, E. H., Bezar, I. F., Petusky, S. L., & Huang, Y. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21580 · Cited by 159
Self-citationpH-Dependent passive and active transport of acidic drugs across Caco-2 cell monolayers
Neuhoff, S., Ungell, A.-L. B., Zamora, I., & Artursson, P. (2005) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.02.009 · Cited by 155
Self-citationTroutman, M. D., & Thakker, D. R. (2003) · Pharmaceutical Research · doi:10.1023/a:1025049014674 · Cited by 154
PAMPA—A drug absorption in vitro model
Avdeef, A., & Tsinman, O. (2006) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.12.008 · Cited by 152
Self-citationExploring the Role of Different Drug Transport Routes in Permeability Screening
Matsson, P., Bergström, C. A. S., Nagahara, N., Tavelin, S., Norinder, U., & Artursson, P. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm049711o · Cited by 147
Self-citationTannergren, C., Bergendal, A., Lennernäs, H., & Abrahamsson, B. (2009) · Molecular Pharmaceutics · doi:10.1021/mp800261a · Cited by 146
Xiang, T., & Anderson, B. D. (1998) · Biophysical Journal · doi:10.1016/s0006-3495(98)77711-2 · Cited by 146
The permeability of liposomes to nonelectrolytes
Cohen, B. E. (1975) · The Journal of Membrane Biology · doi:10.1007/bf01870637 · Cited by 144
Sugano, K., Takata, N., Machida, M., Saitoh, K., & Terada, K. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00240-5 · Cited by 141
Self-citationDiffusion of Small Non-Electrolytes across Liposome Membranes
COHEN, B. E., & Bangham, A. D. (1972) · Nature · doi:10.1038/236173a0 · Cited by 139
Molecular Factors Influencing Drug Transfer across the Blood-Brain Barrier
Gratton, J. A., Abraham, M. H., Bradbury, M. W. B., & Chadha, H. S. (1997) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1997.tb06072.x · Cited by 139
Collett, A., Higgs, N. B., Sims, E. J., Rowland, M., & Warhurst, G. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37939-x · Cited by 136
Intestinal Drug Transporters: In Vivo Function and Clinical Importance
Kunta, J. R., & Sinko, P. J. (2004) · Current Drug Metabolism · doi:10.2174/1389200043489144 · Cited by 133
Pedersen, J. M., Matsson, P., Bergström, C. A. S., Norinder, U., Hoogstraate, J. A., & Artursson, P. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm7015683 · Cited by 131
Self-citationRussell, T., Stoltz, M., & Weir, S. J. (1998) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(98)90052-2 · Cited by 131
Transport Characteristics of Fexofenadine in the Caco-2 Cell Model
Petri, N., Tannergren, C., Rungstad, D., & Lennernäs, H. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000036913.90332.b1 · Cited by 130
Lee, V. H. L. (2000) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(00)00163-9 · Cited by 129
Winterhalter, M. (2000) · Current Opinion in Colloid & Interface Science · doi:10.1016/s1359-0294(00)00063-7 · Cited by 128
Döppenschmitt, S., Spahn-Langguth, H., Regårdh, C. G., & Langguth, P. (1999) · Journal of Pharmaceutical Sciences · doi:10.1021/js980378j · Cited by 127
Danelian, E., Karlén, A., Karlsson, R., Winiwarter, S., Hansson, A., Löfås, S., Lennernäs, H., & Hämäläinen, M. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm991156g · Cited by 127
Influence of Passive Permeability on Apparent P-glycoprotein Kinetics
Lentz, K. A., Polli, J. W., Wring, S. A., Humphreys, J. E., & Polli, J. E. (2000) · Pharmaceutical Research · doi:10.1023/a:1007692622216 · Cited by 126
van de Steeg, E., van der Kruijssen, C. M. M., Wagenaar, E., Burggraaff, J. E. C., Mesman, E. M., Kenworthy, K. E., & Schinkel, A. H. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.024315 · Cited by 125
Permeability, Transport, and Metabolism of Solutes in Caco-2 Cell Monolayers: A Theoretical Study
Sun, H., & Pang, K. S. (2007) · Drug Metabolism and Disposition · doi:10.1124/dmd.107.015321 · Cited by 124
Effects of Intestinal CYP3A4 and P-Glycoprotein on Oral Drug Absorption—Theoretical Approach
Ito, K., Kusuhara, H., & Sugiyama, Y. (1999) · Pharmaceutical Research · doi:10.1023/a:1018872207437 · Cited by 123
Trotter, P. J., & Storch, J. (1991) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42090-5 · Cited by 123
The Role of Size and Charge for Blood–Brain Barrier Permeation of Drugs and Fatty Acids
Seelig, A. (2007) · Journal of Molecular Neuroscience · doi:10.1007/s12031-007-0055-y · Cited by 118
The effect of L‐leucine on the absorption of levodopa, studied by regional jejunal perfusion in man.
Lennernäs, H., Nilsson, D., Sm, A., Ahrenstedt, Ö., Knutson, L., & Paalzow, L. (1993) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1993.tb05691.x · Cited by 118
Lappin, G., Shishikura, Y., Jochemsen, R., Weaver, R. J., Gesson, C., Houston, B., Oosterhuis, B., Bjerrum, O. J., Rowland, M., & Garner, R. C. (2010) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2010.03.009 · Cited by 117
Prediction of human intestinal permeability using artificial membrane permeability
Sugano, K., Nabuchi, Y., Machida, M., & Aso, Y. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00161-3 · Cited by 116
Self-citationTavelin, S., Taipalensuu, J., Söderberg, L., Morrison, R., Chong, S., & Artursson, P. (2003) · Pharmaceutical Research · doi:10.1023/a:1022699920043 · Cited by 115
Self-citationpH-Dependent and Carrier-mediated Transport of Salicylic Acid Across Caco-2 Cells
Takanaga, H., Tamai, I., & Tsuji, A. (1994) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1994.tb03858.x · Cited by 112
Kruijtzer, C. M. F., Beijnen, J. H., & Schellens, J. H. M. (2002) · The Oncologist · doi:10.1634/theoncologist.7-6-516 · Cited by 110
Transport of drugs by proton-coupled peptide transporters: pearls and pitfalls
Brandsch, M. (2009) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425250903042292 · Cited by 108
Chiou, W. L., Chung, S. M., Wu, T. C., & Ma, C. (2001) · International Journal of Clinical Pharmacology and Therapeutics · doi:10.5414/cpp39093 · Cited by 106
Model Analysis of the Concentration-Dependent Permeability of P-gp Substrates
Tachibana, T., Kitamura, S., Kato, M., Mitsui, T., Shirasaka, Y., Yamashita, S., & Sugiyama, Y. (2010) · Pharmaceutical Research · doi:10.1007/s11095-009-0026-9 · Cited by 104
Matsushima, S., Maeda, K., Inoue, K., Ohta, K., Yuasa, H., Kondo, T., Nakayama, H., Horita, S., Kusuhara, H., & Sugiyama, Y. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.023911 · Cited by 104
Development and evaluation of an in vitro method for prediction of human drug absorption
Corti, G., Maestrelli, F., Cirri, M., Zerrouk, N., & Mura, P. (2006) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.11.005 · Cited by 100
Poirier, A., Lavé, T., Portmann, R., Brun, M.-E., Senner, F., Kansy, M., Grimm, H.-P., & Funk, C. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.020750 · Cited by 100
Self-citationBeigi, F., Gottschalk, I., Hägglund, C. L., Haneskog, L., Brekkan, E., Zhang, Y., Österberg, T., & Lundahl, P. (1998) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(97)00398-0 · Cited by 98
Biopharmaceutics Classification System: Validation and Learnings of an in Vitro Permeability Assay
Thiel-Demby, V. E., Humphreys, J. E., Williams, L. A. S. J., Ellens, H. M., Shah, N., Ayrton, A. D., & Polli, J. W. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800122b · Cited by 98
Enhancing the Hit-to-Lead Properties of Lead Optimization Libraries
Pickett, S. D., McLay, I. M., & Clark, D. E. (1999) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci990261w · Cited by 98
QSAR study on permeability of hydrophobic compounds with artificial membranes
Fujikawa, M., Nakao, K., Shimizu, R., & Akamatsu, M. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.03.040 · Cited by 97
Transport of Angiotensin-Converting Enzyme Inhibitors by H+/Peptide Transporters Revisited
Knütter, I., Wollesky, C., Kottra, G., Hahn, M. G., Fischer, W., Zebisch, K., Neubert, R. H. H., Daniel, H., & Brandsch, M. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.143339 · Cited by 95
Bioavailability and pharmacokinetics of cimetidine
Grahnén, A., von Bahr, C., Lindström, B., et al. (1979) · European Journal of Clinical Pharmacology · doi:10.1007/bf00605632 · Cited by 90
Tannergren, C. (2003) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(03)00238-8 · Cited by 88
Matsushima, S., Maeda, K., Ishiguro, N., Igarashi, T., & Sugiyama, Y. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.107.017814 · Cited by 88
Miret, S., Abrahamse, L., & de Groene, E. M. (2004) · SLAS DISCOVERY · doi:10.1177/1087057104267162 · Cited by 88
Taxol transport by human intestinal epithelial Caco-2 cells.
Walle, U. K., & Walle, T. (1998) · PubMed · Cited by 87
PAMPA—a drug absorption in vitro model
Nielsen, P. E., & Avdeef, A. (2004) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2004.02.003 · Cited by 85
Self-citationLennernäs, H. (2007) · Current Drug Metabolism · doi:10.2174/138920007782109823 · Cited by 85
Saitoh, R., Sugano, K., Takata, N., Tachibana, T., Higashida, A., Nabuchi, Y., & Aso, Y. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000026423.48583.e2 · Cited by 85
Self-citationChen, C., Liu, X., & Smith, B. J. (2003) · Current Drug Metabolism · doi:10.2174/1389200033489415 · Cited by 83
Implications of the Dominant Role of Transporters in Drug Uptake by Cells (Supplementary Material)
Dobson, P. D., Lanthaler, K., Oliver, S. G., & Kell, D. B. (2009) · Current Topics in Medicinal Chemistry · doi:10.2174/156802609787521616 · Cited by 83
Fischer, H., Kansy, M., Avdeef, A., & Senner, F. (2007) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2007.02.001 · Cited by 82 · cited 1×
“The influence of charge distribution on the permeation of cationic amphiphilic compounds has been described, showing that permanently charged lipophilic molecules can pass membranes provided that the charge can be spread over several aromatic ring systems or neutralized by making an ion pair complex with a counter anio”
BackgroundSelf-citationH�gerle, M. L., & Winne, D. (1983) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00508339 · Cited by 81
Cao, X., Yu, L. X., Barbaciru, C., Landowski, C. P., Shin, H., Gibbs, S. T., Miller, H. A., Amidon, G. L., & Sun, D. (2005) · Molecular Pharmaceutics · doi:10.1021/mp0499104 · Cited by 80
Lipophilicity and drug activity
Kubinyi, H. (1979) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-7105-1_5 · Cited by 79
Prediction of human pharmacokinetics — renal metabolic and excretion clearance
Fagerholm, U. (2007) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.59.11.0002 · Cited by 79
A New Model of Weak Acid Permeation through Membranes Revisited: Does Overton Still Rule?
Saparov, S. M., Antonenko, Y. N., & Pohl, P. (2006) · Biophysical Journal · doi:10.1529/biophysj.106.084343 · Cited by 78
Dagenais, C., Avdeef, A., Tsinman, O., Dudley, A., & Béliveau, R. (2009) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2009.06.009 · Cited by 77
Self-citationTannergren, C., Knutson, T. W., Knutson, L., & Lennernäs, H. (2003) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2003.01722.x · Cited by 75
Ano, R., Kimura, Y., Shima, M., Matsuno, R., Ueno, T., & Akamatsu, M. (2003) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2003.10.002 · Cited by 73
A novel screening strategy to identify ABCB1 substrates and inhibitors
von Richter, O., Glavinas, H., Krajcsi, P., Liehner, S., Siewert, B., & Zech, K. (2008) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-008-0345-0 · Cited by 68
Jantratid, E., Prakongpan, S., Dressman, J., Amidon, G. L., Junginger, H. E., Midha, K. K., & Barends, D. M. (2006) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20614 · Cited by 67
How does P-glycoprotein recognize its substrates?
Seelig, A. (1998) · PubMed · Cited by 64
Mechanism of multidrug resistance in relation to passive membrane permeation
Eytan, G. D. (2005) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2005.01.003 · Cited by 64
Human Jejunal Permeability of Two Polar Drugs: Cimetidine and Ranitidine
Takamatsu, N., Kim, O., Welage, L. S., Idkaidek, N., Hayashi, Y., Barnett, J. L., YAMAMOTO, R., Lipka, E., Lennernäs, H., Hussain, A. S., et al. (2001) · Pharmaceutical Research · doi:10.1023/a:1011020025338 · Cited by 64
Entrapment by Cremophor EL decreases the absorption of paclitaxel from the gut
Bardelmeijer, H. A., Ouwehand, M., Malingré, M. M., et al. (2001) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-001-0394-2 · Cited by 63
Xlang, T.-X., & Anderson, B. D. (1994) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600831027 · Cited by 62
Development and evaluation of an in vitro method for prediction of human drug absorption
Corti, G., Maestrelli, F., Cirri, M., Furlanetto, S., & Mura, P. (2005) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.11.004 · Cited by 62
High‐Throughput Artificial Membrane Permeability Studies in Early Lead Discovery and Development
Kansy, M., Fischer, H., Kratzat, K., Senner, F., Wagner, B., & Parrilla, I. (2001) · Wiley eBooks · doi:10.1002/9783906390437.ch24 · Cited by 60
Self-citationComparison of passive drug transport through Caco-2 cells and artificial membranes
Camenisch, G., Folkers, G., & Waterbeemd, H. V. D. (1997) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(96)04796-5 · Cited by 60
Intestinal surface acid microclimate in vitro and in vivo in the rat.
Hm, S., Blair, J. A., Ml, L., & Me, H. (1986) · PubMed · Cited by 58
Loidl‐Stahlhofen, A., Eckert, A., Hartmann, T., & Schöttner, M. (2001) · Journal of Pharmaceutical Sciences · Cited by 57
Prediction of oral drug absorption in humans by theoretical passive absorption model
Obata, K., Sugano, K., Saitoh, R., Higashida, A., Nabuchi, Y., Machida, M., & Aso, Y. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.01.005 · Cited by 56
Self-citationOgihara, T., Kamiya, M., Ozawa, M., Fujita, T., Yamamoto, A., Yamashita, S., Ohnishi, S., & ISOMURA, Y. (2006) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.21.238 · Cited by 56
Sköld, C., Winiwarter, S., Wernevik, J., Bergström, F., Engström, L., Allen, R., Box, K. J., Comer, J. E. A., Mole, J., Hallberg, A., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0506219 · Cited by 55
Nagahara, N., Tavelin, S., & Artursson, P. (2004) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20206 · Cited by 54
Self-citationMasungi, C., Mensch, J., Dijck, A. V., Borremans, C., Willems, B., Mackie, C. E., Noppe, M., & Brewster, M. (2008) · Die Pharmazie · doi:10.31083/ph.2008.7327 · Cited by 52
Stephens, R. H., O’Neill, C. A., Bennett, J., Humphrey, M., Henry, B., Rowland, M., & Warhurst, G. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704668 · Cited by 51
Balimane, P. V., Pace, E., Chong, S., Zhu, M., Jemal, M., & Pelt, C. K. V. (2005) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2005.03.043 · Cited by 47
HPLC-Based Method for Estimating the Temperature Dependence ofn-Octanol−Water Partition Coefficients
Lei, Y. D., Wania, F., Shiu, W. Y., & Boocock, D. G. B. (2000) · Journal of Chemical & Engineering Data · doi:10.1021/je9902488 · Cited by 45
Is PAMPA a useful tool for discovery?
Galinis‐Luciani, D., Nguyen, L., & Yazdanian, M. A. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21071 · Cited by 44
Huang, L., Berry, L., Ganga, S., Janosky, B., Chen, A., Roberts, J. T., Colletti, A. E., & Lin, M.-H. J. (2009) · Drug Metabolism and Disposition · doi:10.1124/dmd.109.029066 · Cited by 44
Avdeef, A., Kansy, M., Bendels, S., & Tsinman, K. (2007) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2007.09.009 · Cited by 43
Self-citationIonization-specific analysis of human intestinal absorption
Reynolds, D. P., Lanevskij, K., Japertas, P., Didžiapetris, R., & Petrauskas, A. A. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21730 · Cited by 43
The permeability of liposomes to nonelectrolytes
Cohen, B. E. (1975) · The Journal of Membrane Biology · doi:10.1007/bf01870638 · Cited by 43
Transporters in Absorption, Distribution, and Elimination
Scherrmann, J. (2009) · Chemistry & Biodiversity · doi:10.1002/cbdv.200900171 · Cited by 43
Fagerholm, U. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9397-y · Cited by 41
Takagi, M., Taki, Y., Sakane, T., NADAI, T., Sezaki, H., Oku, N., & Yamashita, S. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37527-5 · Cited by 40
In silico strategies for modeling membrane transporter function
Chang, C. K., Ray, A., & Swaan, P. W. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03429-x · Cited by 35
Permeation characteristics of a hydrophilic basic compound across a bio-mimetic artificial membrane
Sugano, K., Nabuchi, Y., Machida, M., & Asoh, Y. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.02.010 · Cited by 35
Self-citationChiou, W. L., Chung, S. M., & Wu, T. C. (2000) · Pharmaceutical Research · doi:10.1023/a:1007573531947 · Cited by 33
Linnankoski, J., Ranta, V., Yliperttula, M. L., & Urtti, A. O. (2008) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2008.03.001 · Cited by 32
Li, C., Nair, L. G., Liu, T., Li, F., Pichardo, J., Agrawal, S., Chase, R., Tong, X., Uss, A. S., Bogen, S. L., et al. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.10.031 · Cited by 31
Transporter-mediated Intestinal Absorption of Fexofenadine in Rats
Kikuchi, A., Nozawa, T., Wakasawa, T., et al. (2006) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.21.308 · Cited by 31
Oral absorption of ampicillin: role of paracellular route vs. PepT1 transporter
Lafforgue, G., Arellano, C., Vachoux, C., Woodley, J. F., Philibert, C., Dupouy, V., Bousquet‐mélou, A., Gandia, P., & Houin, G. (2008) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2008.00572.x · Cited by 28
Cited by
A BOILED‐Egg To Predict Gastrointestinal Absorption and Brain Penetration of Small Molecules
Daina, A., & Zoete, V. (2016) · ChemMedChem · doi:10.1002/cmdc.201600182 · Cited by 2,549
Exosomes in cancer development, metastasis, and drug resistance: a comprehensive review
Azmi, A. S., Bao, B., & Sarkar, F. H. (2013) · Cancer and Metastasis Reviews · doi:10.1007/s10555-013-9441-9 · Cited by 1,167
Layered double hydroxides: A brief review from fundamentals to application as evolving biomaterials
Mishra, G., Dash, B., & Pandey, S. (2018) · Applied Clay Science · doi:10.1016/j.clay.2017.12.021 · Cited by 930
Getting Across the Cell Membrane: An Overview for Small Molecules, Peptides, and Proteins
Yang, N. J., & Hinner, M. J. (2015) · Methods in Molecular Biology · doi:10.1007/978-1-4939-2272-7_3 · Cited by 826
Oral Druggable Space beyond the Rule of 5: Insights from Drugs and Clinical Candidates
Doak, B. C., Over, B., Giordanetto, F., & Kihlberg, J. (2014) · Chemistry & Biology · doi:10.1016/j.chembiol.2014.08.013 · Cited by 835
Metadata
- Authors
- Sugano, K., Kansy, M., Artursson, P., Avdeef, A., Bendels, S., Di, L., Ecker, G. F., Faller, B., Fischer, H., Gerebtzoff, G., Lennernaes, H., & Senner, F.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2010-08
- Volume
- 9
- Issue
- 8
- Pages
- 597-614
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2031576029
- Cited by
- 649
- References
- 211
- FWCI
- 3.53
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.